Register Login

Kymera Therapeutics Inc (KYMR)

Esposito Pamela 🟡 adjusted position in 5.5K shares (2 derivative) of Kymera Therapeutics, Inc. (KYMR) at $68.52 Transaction Date: Jan 20, 2026 | Filing ID: 016934

Full text
Register to leave comments
  • News bot Jan. 29, 2026, 2:21 p.m.

    🔍 Esposito Pamela (Executive)

    Company: Kymera Therapeutics, Inc. (KYMR)

    Report Date: 2026-01-20

    Transaction Summary:

    • Total transactions: 7
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 5,500
    • Total shares sold: 11,000

    Detailed Transactions and Holdings:

    • Acquired 3,000 shares of Common Stock at $31.2 per share (Direct)
      Date: 2026-01-20 | Code: M | equity_swap_involved: false | shares_owned_after: 3,000.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 2,500 shares of Common Stock at $49.1 per share (Direct)
      Date: 2026-01-20 | Code: M | equity_swap_involved: false | shares_owned_after: 5,500.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 400 shares of Common Stock at $66.68 per share (Direct)
      Date: 2026-01-20 | Code: S | equity_swap_involved: false | shares_owned_after: 5,100.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 4,900 shares of Common Stock at $67.9888 per share (Direct)
      Date: 2026-01-20 | Code: S | equity_swap_involved: false | shares_owned_after: 200.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 200 shares of Common Stock at $68.52 per share (Direct)
      Date: 2026-01-20 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1
    • Sold 3,000 shares of Stock Option (Right to Buy) at $31.2 per share (Derivative)
      Date: 2026-01-20 | Code: M | Expires: 2034-06-18 | equity_swap_involved: false | shares_owned_after: 10,000.00 | transaction_form_type: 4 | Footnotes: F1, F4
    • Sold 2,500 shares of Stock Option (Right to Buy) at $49.1 per share (Derivative)
      Date: 2026-01-20 | Code: M | Expires: 2031-06-15 | equity_swap_involved: false | shares_owned_after: 5,000.00 | transaction_form_type: 4 | Footnotes: F1, F4

    Footnotes:

    • F1: These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person.
    • F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.40 to $66.96, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
    • F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.47 to $68.46, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
    • F4: The shares underlying this stock option are fully vested and exercisable.

Search

News categories